These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 37241961
41. Evaluation of 4-fluoro-7-nitrobenzofurazan as a dual-function chromogenic and fluorogenic probe for tulathromycin and its innovative utility for development of two eco-friendly and high-through microwell assays for analysis of pharmaceutical formulations. Darwish IA, Aljaber KA, Al-Hossaini AM, Alsalhi MS. Spectrochim Acta A Mol Biomol Spectrosc; 2025 Jan 15; 325():125079. PubMed ID: 39232308 [Abstract] [Full Text] [Related]
42. Development and Comparative Evaluation of Two Different Label-Free and Sensitive Fluorescence Platforms for Analysis of Olaparib: A Recently FDA-Approved Drug for the Treatment of Ovarian and Breast Cancer. Darwish IA, Khalil NY. Molecules; 2023 Sep 08; 28(18):. PubMed ID: 37764300 [Abstract] [Full Text] [Related]
43. Use of response surface methodology for development of new microwell-based spectrophotometric method for determination of atrovastatin calcium in tablets. Wani TA, Ahmad A, Zargar S, Khalil NY, Darwish IA. Chem Cent J; 2012 Nov 12; 6(1):134. PubMed ID: 23146143 [Abstract] [Full Text] [Related]
48. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine. Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brøsen K. Eur J Clin Pharmacol; 1996 Nov 12; 51(1):73-8. PubMed ID: 8880055 [Abstract] [Full Text] [Related]
49. Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid. Tin G, Mohamed T, Shakeri A, Pham AT, Rao PPN. ACS Chem Neurosci; 2019 Jan 16; 10(1):226-234. PubMed ID: 30157623 [Abstract] [Full Text] [Related]
50. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. J Clin Psychopharmacol; 1998 Aug 16; 18(4):274-81. PubMed ID: 9690692 [Abstract] [Full Text] [Related]
55. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Mos J, Mollet I, Tolboom JT, Waldinger MD, Olivier B. Eur Neuropsychopharmacol; 1999 Jan 16; 9(1-2):123-35. PubMed ID: 10082238 [Abstract] [Full Text] [Related]
56. The pharmacogenetics of the selective serotonin reuptake inhibitors. Brøsen K. Clin Investig; 1993 Dec 16; 71(12):1002-9. PubMed ID: 8124052 [Abstract] [Full Text] [Related]
58. [Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study]. Vinnikova MA, Severtsev VV, Komarov SD, Vdovin AS. Zh Nevrol Psikhiatr Im S S Korsakova; 2021 Dec 16; 121(12):57-62. PubMed ID: 35041313 [Abstract] [Full Text] [Related]
60. Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients. Eap CB, Baumann P. J Chromatogr B Biomed Appl; 1996 Nov 08; 686(1):51-63. PubMed ID: 8953192 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]